Preliminary Program.

Malaria in a Global Health Context

8:30AM PROFESSOR BARBARA MCPAKE, Director, Nossal Institute for Global Health, University of Melbourne
Malaria in the broader context of Universal Health Coverage and the Sustainable Development Goal


  Chair: DR WINNIE MPANJU-SHUMBUSHO, Chair, RBM Partnerships

Panellist: Lelio Marmora, CEO, UNITAID; Ruby Shang, Chair of Board of Directors, Asia Pacific Leaders Malaria Alliance;  Bob Aitken, Rotary International
The Role of Global and Regional partnerships


  Engaging & sustaining community involvement: Identifying, mobilising, influencing, and supporting community involvement in Health/Disease control Next generation antimalarials & Engagement & role of the private sector Tools for interrupting transmission and surveillance  & Integrated control of vector borne disease Malaria Elimination Task Force Project (METF) - Malaria elimination on the frontline

Chair: Dr David Reddy, CEO, Medicines for Malaria VentureDr BT Slingsby, CEO, Global Health Innovation Fund Chair: Prof Janet Hemingway, Liverpool School of Tropical Medicine & Prof Tom Burkot, James Cook University Chairs:  
Prof Francois Nosten, Director, Shoklo Malaria Research Unit
  Interactive facilitated discussion Panel: Define communication and coordination channels between and among country and regional Civil society networks. Discuss resources and work needed to engage CSOs and mobilise the needed resources. Discuss community and civil society expectations on, and commitments to support and contribute towards success. Dr David Reddy, CEO, Medicines for Malaria Venture Prof Anthony James, University of California, Irvine
Mosquito population modification and the malaria eradication agenda
Prof Francois Nosten, Director, Shoklo Malaria Research Unit
Introduction to METF
    Prof Sue Charman, Monash Institute of Pharmaceutical Sciences
The Importance of PK to Meet Current Target Candidate Profiles
Prof Olivo Miotto, Mahidol Oxford Tropical Research Unit
Genetic surveillance of drug-resistant malaria to support elimination in the Greater Mekong Subregion"
Aung Paye Phyo (AAF nominee) 
ACT Resistance on the Thai-Myanmar Border 
    Prof James McCarthy, Head of Clinical Tropical Medicine, QIMR Berghofer Dr Gerry Killeen, Liverpool School of Tropical Medicine
Entomological surveillance as a cornerstone of malaria elimination: a critical appraisal
Dr Jordi Landier, Shoklo Malaria Research Unit
Strategy of METF and Impact
    Dr BT Slingsby, CEO, Global Health Innovative Technology Fund (GHIT) Nancy Matowo, Ifakara Health Instittute
Fine-scale spatial and temporal heterogeneities in insecticide resistance profiles of Anopheles arabiensis in rural south-eastern Tanzania
Aung Myint Thu (AAF nominee)
Trends in molecular markers and resistance 
    Dr Graham Hancock, General Manager, Newcrest Business Case for engagement in malaria elimination for Newcrest Mining Limited Professor Tom Burkot, James Cook University
Malaria Vector Monitoring: Can vector data guide global policy and programmatic decision-making?
Ladda Kajeechiwa, Shoklo Malaria Research Unit
Community engagement in malaria elimination

Panel Discussion
Jayeeta Chowdhury, Tata Trusts
Ray Nishimoto, Senior Managing Executive Officer, Sumitomo Chemical Company
Dr Graham Hancock, General Manager, Newcrest
Dr Wit Soontaranun, President, DT Families Foundation

Dr Kim Lindblade, World Health Organisation
Global vector control response: a strategic approach to tackle vector-borne diseases
Jade Rae, Shoklo Malaria Research Unit
Importance of monitoring and evaluation
      Dr Louise Kelly-Hope, Liverpool School of Tropical Medicine
Lessons learnt from integrated control - drug-based methods
Dr Victor Chaumeau, Shoklo Malaria Research Unit
Entomological determinants of malaria elimination
      Dr Nick Hamon, CEO IVCC
Saving lives through innovation in vector control collaborative efforts leading to novel solutions in vector control
Lisa White and Ricardo Aguas
Mathematical models to extend and extrapolate the empirical evidence on targeted malaria elimination
        Cindy Chu
Prospects of P.Vivax Elimination
        Professor Arjen Dondorp
Governance, politics & conclusion
        Panel Discussion/Q&A


  Mobile people & populations: understanding & meeting needs Malaria elimination efforts in the Greater Mekong Region & Health Systems Strengthening, Universal Health Coverage & Sustainable Development Goals in Malaria Triple combination therapy for multidrug resistant malaria & Global health security & AMR Australia-China-Papua New Guinea Trilateral Malaria Project

Chair: Prof Barbara McPake, Nossal Institute of Global Health Chair: Dr Ben Rolfe, Asia Pacific Leaders Malaria Alliance

Chair: Pascoe Kase, Secretary of Health, Papua New Guinea

  Louis De Gama
Overview of mobility and universal health access - what do we know

Tran Thanh Duong, Director of NIMPE
Malaria Elimination efforts in Vietnam
Prof Arjen Dondorp, Mahidol University
Background and rationale for triple artemisinin combination therapies in falciparum malaria
Dr Evelyn Lavu, CPHL
Stengthening capacity for quality malaria diagnosis in PNG
    Dr Lek Dysoley, National Malaria Program, Cambodia Robin Davies, Head, Indo-Pacific Centre for Health Security, DFAT
The intersection of Australia's Leadership in Malaria Elimination and Health Security
Dr Junhu Chen, NIPD
Provision of technical expertise in malaria diagnostics and control
  Sai Ti, ARC
Migrant health volunteers engagement in malaria elimination in Thailand
Dr Sengchanh Kounnavong (AAF nominee), Director General, NIOPH, Lao PDR  Aparnaa Somanathan, World Bank
Financing core health systems for essential services and security: integrating the agendas
Dr William Pomat, PNGIMR
Trilateral Malaria Project Operational Research: An Update
  Lorina McAdam, Population Services International (PSI)
One size does not fit all: a tailored approach to diverse plantation worker preferences
Dr Stephanie Williams, Principal Sector Specialist for Health, Australian Department of Foreign Affairs & Trade Dr Marie Lamy, APLMA

Panel Discussion: Building effective partnerships for collaborative action against malaria

Panellist: Mr Leo Makita, NDOH
Dr Moses Laman, PNG IMR
Professor Zhou Xiao-Nong, NIPD
Dr Leanne Robinson, Burnet Institute
Will Robinson, Councillor, Australian High Commision

Panel discussion led by Ms Sarah MacCana, Project Partnership Manager

  Kylie Mannion, Malaria Consortium, Cambodia
Mobile malaria services reaching border crossers, ethnic communities and forest goers in North East Cambodia
Dr Susann Roth, Senior Social Development Specialist, Asia Development Bank    
  Panel Discussion: Meeting migrant and mobile peoples needs and wants: Lessons from the Greater Mekong Region Dr Jim Tulloch, Technical Evaluation Reference Group, the Global Fund to Fight AIDS, Tuberculosis and Malaria    
  Emmanuel Odjidja (Burundi)
Prevention of malaria in pregnancy amongst pastoralists in a humanitarian setting: an exploratory study
  Aung Ye Naung Win (Myanmar)
Understanding malaria treatment seeking preferences within the public sector amongst migrant/mobile workers in a malaria elimination scenario: A mixed methods case study 
  Benjamin Bob
The social co-relation between malaria, water sanitation and hygiene among internally displaced people and illegal migrant's health: an epidemiological review of the social implications of migration and population health in SubSaharan Africa
  Q&A Q&A    

3:30PM DR PHILIP WELKHOFF, Bill and Melinda Gates Foundation

4:00PM PROF ARJEN DONDORP, Mahidol-Oxford Tropical Medicine Research Unit
Malaria in global health context

4:30PM PROF JANET HEMINGWAY, Liverpool School of Tropical Medicine 
Vector control in the context of elimination & eradication



  Malaria in Pregnancy Mechanisms of antimalarial activity and resistance Malaria Elimination & Vector Control APLMA/APMEN Dialogue
  Chair: Prof Freya Fowkes, Burnet Institute

Chair: Prof Leann Tilley, The University of Melbourne Chair: Dr Julie Healer, Walter Eliza Hall Institute
  Dr Rukhsana Ahmed, Liverpool School of Tropical Medicine
Intermittent preventive treatment (IPT) or intermittent screening and treatment (IST) with dihydroartemisinin-piperaquine for the control of malaria in pregnancy (MiP) in Indonesia: an open label cluster-randomized controlled trial
Dr Rowena Martin, Australian National University
Transporters as determinants of drug resistance in the malaria parasite.
Dr Michael Coleman, Liverpool School of Tropical Medicine
GIVeS: A collaborative effort for GIS capacity building in vector surveillance
  Dr Verena Carrara, Shoklo Malaria Research Unit
Surveillance of malaria in pregnancy and monitoring the effectiveness of malaria elimination
Dr Ghizal Siddiqui, Monash University
Multi-omics analysis of artemisinin resistant Plasmodium falciparum malaria parasites demonstrates key roles of glutathione and haemoglobin metabolism
Vera Unwin, Liverpool School of Tropical School
A new simple test for the detection of insecticide resistance markers in mosquitoes
  Elaine Roman, Jhpiego
Bringing innovation to malaria in pregnancy through community engagement in Sub Saharan Africa
Dr Darren Creek, Monash University
Elucidation of a novel nuclear mechanism of action for potent bis-triazine antimalarials
Lauren Childs, Virginia Tech
The Impact of Within-Vector Dynamics on Malaria Parasite Diversity
  Katherine Wolf, Jhpiego
Progress on Malaria in Pregnancy in PMI Focus Countries
Dr Hyun Jae Lee, QIMR Berghofer Medical Research Institute
Integrated pathogen load and dual transcriptome analysis of systemic host-pathogen interactions in severe malaria
Melinda Hadi, Vestergaard
The threat of insecticide resistance for malaria control and elimination
  Prof Julie Simpson, The University of Melbourne
Influence of antenatal malaria screening in an area of low transmission on birthweight-for-gestational age
Kit Kennedy, 
Delayed death in the malaria parasite: Prenylation dependant disruption of intracellular trafficking
Mathias Mondy, IVCC
New vector control technologies-Attractive targeted sugar bait
  Prof Rose McGready, Shoklo Malaria Research Unit
Submicroscopic qPCR Plasmodium falciparum and P.vivax infection at the first antenatal visit: maternal and neonatal outcomes
Hosted by Business Alliance Against Malaria (RBM Partnership to End Malaria, APLMA, PSMC)